Kevin Beezhold

1.1k total citations
19 papers, 864 citations indexed

About

Kevin Beezhold is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Kevin Beezhold has authored 19 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Kevin Beezhold's work include MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Kevin Beezhold is often cited by papers focused on MicroRNA in disease regulation (4 papers), Immune Cell Function and Interaction (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Kevin Beezhold collaborates with scholars based in United States, China and Ireland. Kevin Beezhold's co-authors include Vince Castranova, Xianglin Shi, Qingshan Chang, Fei Chen, Aaron Barchowsky, Jianguo Chen, Fei Chen, Hongwen Zhao, Yongju Lu and Fabrisia Ambrosio and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Kevin Beezhold

18 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Beezhold United States 14 599 264 117 82 78 19 864
Chung‐Hsing Chen Taiwan 17 551 0.9× 224 0.8× 171 1.5× 60 0.7× 194 2.5× 35 886
Kuo Yang China 19 497 0.8× 263 1.0× 152 1.3× 37 0.5× 47 0.6× 52 825
Natalia Gorlatova United States 16 438 0.7× 278 1.1× 107 0.9× 124 1.5× 86 1.1× 16 885
Ernesto Soto‐Reyes Mexico 17 623 1.0× 220 0.8× 123 1.1× 37 0.5× 53 0.7× 41 915
Xingrong Guo China 17 586 1.0× 202 0.8× 219 1.9× 45 0.5× 163 2.1× 49 1.1k
S J Chen China 12 1.2k 2.0× 132 0.5× 129 1.1× 47 0.6× 123 1.6× 16 1.4k
Xinping Luo China 15 449 0.7× 155 0.6× 62 0.5× 45 0.5× 94 1.2× 26 834
W-L Zhao China 10 576 1.0× 142 0.5× 134 1.1× 27 0.3× 81 1.0× 12 845

Countries citing papers authored by Kevin Beezhold

Since Specialization
Citations

This map shows the geographic impact of Kevin Beezhold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Beezhold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Beezhold more than expected).

Fields of papers citing papers by Kevin Beezhold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Beezhold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Beezhold. The network helps show where Kevin Beezhold may publish in the future.

Co-authorship network of co-authors of Kevin Beezhold

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Beezhold. A scholar is included among the top collaborators of Kevin Beezhold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Beezhold. Kevin Beezhold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Monlish, Darlene, Kevin Beezhold, Pailin Chiaranunt, et al.. (2021). Deletion of AMPK minimizes graft-versus-host disease through an early impact on effector donor T cells. JCI Insight. 6(14). 5 indexed citations
2.
3.
Dolezal, James M., Huabo Wang, Sucheta Kulkarni, et al.. (2017). Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma. Journal of Biological Chemistry. 292(24). 10068–10086. 40 indexed citations
4.
Beezhold, Kevin & Craig A. Byersdorfer. (2017). Targeting immuno-metabolism to improve anti-cancer therapies. Cancer Letters. 414. 127–135. 14 indexed citations
5.
D’Amore, A., Kevin Beezhold, Benjamin B. Rothrauff, et al.. (2017). Aging of the skeletal muscle extracellular matrix drives a stem cell fibrogenic conversion. Aging Cell. 16(3). 518–528. 192 indexed citations
6.
Byersdorfer, Craig A., et al.. (2017). Deletion of AMP-activated protein kinase (AMPK) in donor T cells mitigates graft-versus-host disease without impacting graft-versus-leukemia effects. The Journal of Immunology. 198(Supplement_1). 82.11–82.11. 1 indexed citations
7.
Beezhold, Kevin, Linda R. Klei, & Aaron Barchowsky. (2016). Regulation of cyclin D1 by arsenic and microRNA inhibits adipogenesis. Toxicology Letters. 265. 147–155. 21 indexed citations
9.
Zhang, Changqing, Kevin Beezhold, A. D’Amore, et al.. (2015). Arsenic Promotes NF-Κb-Mediated Fibroblast Dysfunction and Matrix Remodeling to Impair Muscle Stem Cell Function. Stem Cells. 34(3). 732–742. 28 indexed citations
10.
Anderson, Stacey E., Kevin Beezhold, Ewa Lukomska, et al.. (2013). Expression kinetics of miRNA involved in dermal toluene 2,4-diisocyanate sensitization. Journal of Immunotoxicology. 11(3). 250–259. 16 indexed citations
11.
Chen, Bailing, Jia Liu, Qingshan Chang, et al.. (2012). JNK and STAT3 signaling pathways converge on Akt-mediated phosphorylation of EZH2 in bronchial epithelial cells induced by arsenic. Cell Cycle. 12(1). 112–121. 63 indexed citations
12.
Beezhold, Kevin, Jia Liu, Hong Kan, et al.. (2011). miR-190-Mediated Downregulation of PHLPP Contributes to Arsenic-Induced Akt Activation and Carcinogenesis. Toxicological Sciences. 123(2). 411–420. 88 indexed citations
13.
Beezhold, Kevin, Vince Castranova, & Fei Chen. (2010). Microprocessor of microRNAs: regulation and potential for therapeutic intervention. Molecular Cancer. 9(1). 134–134. 70 indexed citations
14.
Chang, Qingshan, et al.. (2009). JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma. Molecular Cancer. 8(1). 70 indexed citations
15.
Lu, Yongju, Kevin Beezhold, Qingshan Chang, et al.. (2009). Lung cancer-associated JmjC domain protein mdig suppresses formation of tri-methyl lysine 9 of histone H3. Cell Cycle. 8(13). 2101–2109. 76 indexed citations
16.
Chen, Fei, Kevin Beezhold, & Vince Castranova. (2009). JNK1, a potential therapeutic target for hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1796(2). 242–251. 35 indexed citations
17.
Chen, Fei, Kevin Beezhold, & Vince Castranova. (2008). Tumor Promoting or Tumor Suppressing of NF-κ B, a Matter of Cell Context Dependency. International Reviews of Immunology. 27(4). 183–204. 31 indexed citations
18.
Chang, Qingshan, Yadong Zhang, Kevin Beezhold, et al.. (2008). Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer. Journal of Hepatology. 50(2). 323–333. 100 indexed citations
19.
Zhang, Yadong, Kevin Beezhold, Vince Castranova, Xianglin Shi, & Fei Chen. (2008). Characterization of an alternatively spliced GADD45α, GADD45α1 isoform, in arsenic‐treated epithelial cells. Molecular Carcinogenesis. 48(5). 454–464. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026